Poor asthma control? - then look up the nose. The importance of co-morbid rhinitis in patients with asthma

Primary Care Respiratory Journal

Volumn 21, Issue 2, 2012, Pages 222-228

  Scadding, Glenis ^a   Walker, Samantha ^b  

^a ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^b ASTHMA UK   (United Kingdom)

Author keywords

Airway inflammation; Asthma; Co morbidity; Diagnosis; Rhinitis; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; MOMETASONE FUROATE;

ALLERGIC RHINITIS; ANAMNESIS; ASTHMA; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; HUMAN; LABORATORY TEST; PATIENT CARE; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; REVIEW; RHINITIS; SYMPTOMATOLOGY; VASOMOTOR RHINITIS;

ASTHMA; HUMANS; RHINITIS; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX;

EID: 84862677520     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00035     Document Type: Review

References (57)

1. Global Initiative for Asthma (GINA). Revised 2002: Global Strategy for Asthma Management and Prevention. http://www.ginasthma.org/
2. National Heart, Lung, and Blood Institute (NHLBI). Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Full Report 1997. http://www.nhlbi.nih.gov/guidelines/archives/epr-2/asthgdln_archive.pdf
3. British Thoracic Society (BTS). British Guideline on the Management of Asthma. Thorax 2003; 58 Suppl 1. http://www.brit-thoracic.org.uk.
4. Canadian Thoracic Society (CTS). Adult asthma consensus guidelines update 2003. http://www.lung.ca/cts-sct/pdf/Adult_Asthma_Consensus.pdf.
5. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-78. http://dx.doi.org/10.1183/09031936.00138707
6. Calhoun WJ, Sutton LB, Emmett A, Dorinsky PM. Asthma variability in patients previously treated with beta2-agonists alone. J Allergy Clin Immunol 2003;112: 1088-94. http://dx.doi.org/10.1016/j.jaci.2003.09.044
7. Pedersen S. From asthma severity to control: a shift in clinical practice. Prim Care Respir J 2010;19:3-9. http://dx.doi.org/10.4104/pcrj.2009.00059
8. Bateman ED, Boushey HA, Bousquet J, et al. GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170(8):836-44. http://dx.doi.org/10.1164/rccm.200401-033OC
9. Bateman ED, Bousquet J, Busse WW, et al. GOAL Steering Committee and Investigators. Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy 2008;63(7):932-8. http://dx.doi.org/10.1111/j.1398-9995.2008.01724.x
10. Godard P, Greillier P, Pigearias B, Nachbaur G, Desfougeres JL, Attali V. Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study. Respir Med 2008;102(8):1124-31. http://dx.doi.org/10.1016/j.rmed.2008.03.014
11. Pauwels RA, Pedersen S, Busse WW, et al. START Investigators Group. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003;361(9363):1071-6. http://dx.doi.org/10.1016/S0140-6736(03)12891-7
12. Bousquet J, Boulet LP, Peters MJ, et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med 2007; 101(12): 2437-46. http://dx.doi.org/10.1016/j.rmed.2007.07.014
13. Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M. Comparison of adjustable-and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. J Allergy Clin Immunol 2008;121(6):1407-14. http://dx.doi.org/10.1016/j.jaci.2008.03.019
14. Taylor DR, Bateman ED, Boulet LP, et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008;32:545-54. http://dx.doi.org/10.1183/ 09031936.00155307
15. Reddel HK, Taylor DR, Bateman ED, et al. American Thoracic Society/ European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59-99. http://dx.doi.org/ 10.1164/rccm.200801-060ST
16. Levy ML. Guideline-defined asthma control: a challenge for primary care. Eur Respir J 2008;31:229-31. http://dx.doi.org/10.1183/09031936.00157507
17. Horne R, Price D, Cleland J, et al. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007;7:8. http://dx.doi.org/ 10.1186/1471-2466-7-8
18. Corrigan CJ. Asthma therapy: there are guidelines and then there is real life. Prim Care Resp J 2011;20:13-14. http://dx.doi.org/10.4104/pcrj.2011.00016
19. Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009;18:300-05. http://dx.doi.org/10.4104/pcrj.2009.00037
20. Brandão HV, Cruz CS, Pinheiro MC, et al. Risk factors for ER visits due to asthma exacerbations in patients enrolled in a program for the control of asthma and allergic rhinitis in Feira de Santana, Brazil. J Bras Pneumol 2009;35:1168-73.
21. Magnan A, Meunier JP, Saugnac C, Gasteau J, Neukirch F. Frequency and impact of AR in asthma patients in everyday general medical practice: a French observational cross-sectional study. Allergy 2008;63:292-8. http://dx.doi.org/10.1111/j.1398-9995.2007.01584.x
22. Angier E, Willington J, Scadding G, Holmes S, Walker S. Management of allergic and non-allergic rhinitis: a primary care summary of the BSACI guideline. Prim Care Resp J 2010;19:217-22. http://dx.doi.org/10.4104/pcrj.2010.00044
23. Allergic Rhinitis and its Impact on Asthma (ARIA). http://www.whiar.org/Documents&Resources.php
24. Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003; 58:691-706. http://dx.doi.org/10.1034/j.1398-9995.2003.00105.x
25. Leynaert B, Neukirch C, Kony S, et al. Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol 2004;113:86-93. http://dx.doi.org/10.1016/j.jaci.2003.10.010
26. Linneberg A, Henrik Nielsen N, Frolund L, Madsen F, Dirksen A, Jorgensen T. The link between AR and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy 2002;57:1048-52. http://dx.doi.org/10.1034/ j.1398-9995.2002.23664.x
27. Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of AR. Allergy 2005;60:350-3. http://dx.doi.org/10.1111/j.1398-9995.2005.00751.x
28. Slavin RG. The upper and lower airways: the epidemiological and pathophysiological connection. Allergy asthma proc 2008;29:553-6. http://dx.doi.org/10.2500/ aap.2008.29.3169
29. Simons FER. Allergic rhinobronchitis: the asthma-AR link. J Allergy Clin Immunol 1999;104:534-40. http://dx.doi.org/10.1016/S0091-6749(99)70320-9
30. Braunstahl GJ. The unified immune system: Respiratory tract nasobronchial interaction mechanisms in allergic airway disease. J Allergy Clin Immunol 2005; 115:142-8. http://dx.doi.org/10.1016/j.jaci.2004.10.041
31. Rowe-Jones JM. The link between the nose and the lung, perennial rhinitis and asthma-is it the same disease? Allergy 1997;52(suppl 36):20-8. http://dx.doi.org/10.1111/j.1398-9995.1997.tb04818.x
32. Durham SR. Mechanisms of mucosal inflammation in the nose and lungs. Clin Exp Allergy 1998;28(Suppl 2):11-16.
33. Togias A. Mechanisms of nose-lung interaction. Allergy 1999;54(Suppl 57):94-105. http://dx.doi.org/10.1111/j.1398-9995.1999.tb04410.x
34. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992;89:611-18. http://dx.doi.org/10.1016/0091-6749(92)90329-Z
35. Inal A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB, Erdogan S. Indices of lower airway inflammation in children monosensitized to house dust mite after nasal allergen challenge. Allergy 2008;63:1345-51. http://dx.doi.org/10.1111/j.1398-9995.2008.01694.x
36. Bonay M, Neukirch C, Grandsaigne M, et al. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Allergy 2006;61: 111-18. http://dx.doi.org/10.1111/j.1398-9995.2006.00967.x
37. Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in AR patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001;164:858-65.
38. Braunstahl GJ, KleinJan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in AR patients. Am J Respir Crit Care Med 2000;161:2051-7.
39. Fasano MB. Combined airways: impact of upper airway on lower airway. Curr Opin Otolaryngol Head Neck Surg 2010;18:15-20. http://dx.doi.org/10.1097/ MOO.0b013e328334aa0e
40. Downie SR, Andersson M, Rimmer J, et al. Association between nasal and bronchial symptoms in subjects with persistent AR. Allergy 2004;59:320-6. http://dx.doi.org/10.1111/j.1398-9995.2003.00419.x
41. Thomas M. AR: evidence for impact on asthma. BMC Pulm Med 2006;6 Suppl 1:S4. http://dx.doi.org/10.1186/1471-2466-6-S1-S4
42. Taramarcaz P, Gibson PG. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database Sys Rev 2003;4: CD003570.
43. Baiardini I, Villa E, Rogkakou A, et al. Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. Clin Exp Allergy 2011;41: 417-23. http://dx.doi.org/10.1111/j.1365-2222.2010.03660.x
44. Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372:1049-57. http://dx.doi.org/10.1016/ S0140-6736(08)61446-4
45. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109:419-25. http://dx.doi.org/10.1067/mai.2002.121701
46. Leynaert B, Neukirch C, Kony S. Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol 2004; 113: 86-93. http://dx.doi.org/10.1016/j.jaci.2003.10.010
47. Burgess JA, Walters EH, Byrnes GB, et al. Childhood AR predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol 2007; 120:863-9. http://dx.doi.org/10.1016/j.jaci.2007.07.020
48. Plaschke PP, Janson C, Norrman E, Björnsson E, Ellbär S, Järvholm B. Onset and remission of AR and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med 2000;162:920-4.
49. Bugiani M, Carosso A, Migliore E, et al. AR and asthma comorbidity in a survey of young adults in Italy. Allergy 2005;60:165-70. http://dx.doi.org/10.1111/j.1398-9995.2005.00659.x
50. Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a concomitant diagnosis of AR on asthma-related health care use by adults. Clin Exp Allergy 2005;35:282-7. http://dx.doi.org/10.1111/j.1365-2222.2005.02182.x
51. Crystal-Peters J, Neslusan CA, Smith MW, Togias A. Health care costs of ARassociated conditions vary with allergy season. Ann Allergy Asthma Immunol 2002;89:457-62. http://dx.doi.org/10.1016/S1081-1206(10)62081-9
52. Braido F, Baiardini I, Balestracci S, et al. Does asthma control correlate with quality of life related to upper and lower airways? A real life study. Allergy 2009;64:937-43. http://dx.doi.org/10.1111/j.1398-9995.2008.01932.x
53. Lack G. Pediatric AR and comorbid disorders. J Allergy Clin Immunol 2001;108(1 Suppl):S9-15. http://dx.doi.org/10.1067/mai.2001.115562
54. Sur DK, Scandale S. Treatment of AR. Am Fam Physician 2010;81:1440-6.
55. Nathan RA. Management of patients with AR and asthma: literature review. South Med J 2009;102:935-41. http://dx.doi.org/10.1097/SMJ.0b013e3181b01c68
56. Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 2008;38:19-42. http://dx.doi.org/10.1111/j.1365-2222.2007.02888.x
57. Walker S, Sheikh A. Rhinitis-10-minute consultation. BMJ 2002;324:403. http://dx.doi.org/10.1136/bmj.324.7334.403